Chittorgarh.com Logo
Loading...

Indo US BioTech IPO Details

Issue Open Apr 30, 2018
Issue Close May 3, 2018
IPO Price ₹51
Face Value ₹10
IPO Size ₹7.29 Cr
Listing At BSE SME
IPO Lot Size 2000
  1. The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO

    Fri, 06 Aug 2021 05:19:00 GMT

    Here's a roundup of top developments in the biotech space over the last 24 hours ... use authorization of its vaccine in India, Indonesia and the Philippines. The company announced second ...

  2. Long-termism as Investment Philosophy: Healthcare Investor Sangel Capital Expects to See Big Rise in Investment Value

    Tue, 21 Sep 2021 10:00:00 GMT

    The portfolio value of Sangel Capital ("Sangel" or the "Company"), a leading biotech and healthcare venture capital company based in China, is poised for strong growth as multiple biotech and ...

  3. Indonesias GoTo set to wrap up $2 billion funding round, eyes IPO in 2022 -sources

    Thu, 19 Aug 2021 02:33:00 GMT

    SINGAPORE (Reuters) - Indonesia's biggest tech group GoTo is set to complete a pre-IPO funding exercise to raise up to $2 billion in the next few weeks, but regulatory delays threaten to push its ...

  4. Secretlab to ShopBack: LinkedIn unveils top 15 Sípore startups to look out for in 2021

    Wed, 22 Sep 2021 18:45:00 GMT

    This is why LinkedInís list of Top Startups 2021 serves as a source of encouragement and hope. To put together this yearís rankings, LinkedIn accessed their data across four pillars: employee growth, ...

  5. AM-Pharma Appoints Lars Boesgaard as Chief Financial Officer and Establishes U.S. Affiliate AM-Pharma Inc.

    Wed, 15 Sep 2021 02:00:00 GMT

    Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced the appointment of Lars R. Boesgaard as Chief Financial Officer (CFO), effective ...

  6. An IPO Love Affair With US Stock Market Means A Shakeup Is Near

    Mon, 30 Aug 2021 16:59:00 GMT

    In other words, the companies are not receiving IPO cash to foster growth - like for innovation or expansion. Then there are the surefire Wall Street money machines of SPAC funds, "biotech ...

  7. ALB Asia M&A Rankings 2021

    Sun, 12 Sep 2021 17:00:00 GMT

    Mergers and acquisitions (M&A) deals picked up steam throughout Asia Pacific during the first half of 2021, in no small measure due to a rebound from the worst economic ravages of the COVID-19 ...

  8. Meris DDoS persists. REvil has returned. Chinese operators hit Indonesias government. DPRK charm. Al Qaeda marks 9/11.

    Mon, 13 Sep 2021 07:51:00 GMT

    Meris DDoS proving difficult to stop. REvil has apparently returned. Chinese operators hit Indonesia's government (including its principal intelligence service). DPRK's preparatory charm offensive. Al ...

  9. These 10 self-made tech tycoons worked their way up and are now Síporeís 50 richest

    Thu, 09 Sep 2021 08:13:00 GMT

    Following the launch of Razerís first smartphone, Tan listed the firm in Hong Kong in November 2017, raising US$529 million. The IPO then made him the youngest ... which focuses on biotech, agri-tech, ...

  10. Yenher on track for double-digit growth

    Sun, 05 Sep 2021 17:00:00 GMT

    Cheng said the group had recently inked a three-year distribution deal worth US$200,000 (RM829,300) annually with a customer in Taiwan for livestock biotech products developed in-house.

  11. LONDON MARKET PRE-OPEN: Ashtead lifts outlook; Ryanair plots growth

    Wed, 15 Sep 2021 23:46:00 GMT

    Stock prices in London are seen cautiously opening higher, despite a weak handover from Asia, though economic uncertainty is keeping a lid on gains. In early UK corporate news, equipment rental firm ...

Indo US BioTech IPO Alerts

1. Indo US BioTech IPO Listing Date & Info  Tuesday, May 15, 2018 6:16:22 AM

The IPO Shares of Indo US Bio-Tech Limited IPO are proposed to list on Friday, May 11, 2018 at BSE SME. The public issue of Indo US BioTech IPO was opened on Apr 30, 2018 and closed for subscription on May 3, 2018. Indo US BioTech IPO Listing Date and Information:

  • Listing Date: Friday, May 11, 2018
  • BSE Script Code: 541304
  • NSE Symbol:
  • Listing In: MT
  • ISIN: INE250Z01010
  • Issue Price: 51
  • Face Value: 10

2. Indo US BioTech IPO Allotment Status  Tuesday, May 8, 2018 11:38:36 AM

The allotment status of Indo US Bio-Tech Limited IPO is now available online. The public issue of Indo US BioTech IPO was open on Apr 30, 2018 and closed for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME.

3. Indo US BioTech IPO Closes on May 3, 2018  Tuesday, April 17, 2018 8:41:07 AM

The issue of Indo US Bio-Tech Limited opens on Apr 30, 2018 and closes for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 51 Per Equity Share.

4. Indo US BioTech IPO Opens on Apr 30, 2018  Sunday, April 8, 2018 3:10:43 AM

Indo US Bio-Tech Limited is entering in the capital market with an IPO of 1,430,000 Equity Shares of Rs 10 aggregating up to Rs 72.93 Crore. The price for the issue has been set at Rs 51 Per Equity Share.

Incorporated in 2004, Gujarat based Indo US Bio-Tech Limited is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing ). The company has its own laboratory for seed testing at Junagadh.

The issue opens on Apr 30, 2018 and closes for subscription on May 4, 2018. The equity shares of the company to be list at BSE SME.

Indo US BioTech IPO News & Events FAQs

The Indo US BioTech IPO is proposed to open on Apr 30, 2018. The IPO application ends on May 3, 2018.

Retail investors can apply in the retail or non-institutional investor category from Apr 30, 2018 to May 3, 2018. The Indo US BioTech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Indo US BioTech IPO will open for subscription on Apr 30, 2018. The public issue will close on May 3, 2018.